Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Finished Goods: 2020-2024

Historic Finished Goods for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $23.1 million.

  • Maravai Lifesciences Holdings' Finished Goods fell 14.79% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year decrease of 14.79%. This contributed to the annual value of $23.1 million for FY2024, which is 18.98% up from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Finished Goods of $23.1 million as of FY2024, which was up 18.98% from $19.4 million recorded in FY2023.
  • Maravai Lifesciences Holdings' 5-year Finished Goods high stood at $23.1 million for FY2024, and its period low was $3.9 million during FY2020.
  • For the 3-year period, Maravai Lifesciences Holdings' Finished Goods averaged around $16.7 million, with its median value being $19.4 million (2023).
  • In the last 5 years, Maravai Lifesciences Holdings' Finished Goods soared by 170.98% in 2021 and then declined by 26.16% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Finished Goods (Yearly) stood at $3.9 million in 2020, then spiked by 170.98% to $10.4 million in 2021, then dropped by 26.16% to $7.7 million in 2022, then soared by 151.15% to $19.4 million in 2023, then grew by 18.98% to $23.1 million in 2024.